COVID-19 Related Coagulopathy: A Distinct Entity?

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summar...

Descripción completa

Detalles Bibliográficos
Autores principales: Marchandot, Benjamin, Sattler, Laurent, Jesel, Laurence, Matsushita, Kensuke, Schini-Kerth, Valerie, Grunebaum, Lelia, Morel, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356260/
https://www.ncbi.nlm.nih.gov/pubmed/32486469
http://dx.doi.org/10.3390/jcm9061651
_version_ 1783558459546927104
author Marchandot, Benjamin
Sattler, Laurent
Jesel, Laurence
Matsushita, Kensuke
Schini-Kerth, Valerie
Grunebaum, Lelia
Morel, Olivier
author_facet Marchandot, Benjamin
Sattler, Laurent
Jesel, Laurence
Matsushita, Kensuke
Schini-Kerth, Valerie
Grunebaum, Lelia
Morel, Olivier
author_sort Marchandot, Benjamin
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.
format Online
Article
Text
id pubmed-7356260
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73562602020-07-31 COVID-19 Related Coagulopathy: A Distinct Entity? Marchandot, Benjamin Sattler, Laurent Jesel, Laurence Matsushita, Kensuke Schini-Kerth, Valerie Grunebaum, Lelia Morel, Olivier J Clin Med Review The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy. MDPI 2020-05-31 /pmc/articles/PMC7356260/ /pubmed/32486469 http://dx.doi.org/10.3390/jcm9061651 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Marchandot, Benjamin
Sattler, Laurent
Jesel, Laurence
Matsushita, Kensuke
Schini-Kerth, Valerie
Grunebaum, Lelia
Morel, Olivier
COVID-19 Related Coagulopathy: A Distinct Entity?
title COVID-19 Related Coagulopathy: A Distinct Entity?
title_full COVID-19 Related Coagulopathy: A Distinct Entity?
title_fullStr COVID-19 Related Coagulopathy: A Distinct Entity?
title_full_unstemmed COVID-19 Related Coagulopathy: A Distinct Entity?
title_short COVID-19 Related Coagulopathy: A Distinct Entity?
title_sort covid-19 related coagulopathy: a distinct entity?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356260/
https://www.ncbi.nlm.nih.gov/pubmed/32486469
http://dx.doi.org/10.3390/jcm9061651
work_keys_str_mv AT marchandotbenjamin covid19relatedcoagulopathyadistinctentity
AT sattlerlaurent covid19relatedcoagulopathyadistinctentity
AT jesellaurence covid19relatedcoagulopathyadistinctentity
AT matsushitakensuke covid19relatedcoagulopathyadistinctentity
AT schinikerthvalerie covid19relatedcoagulopathyadistinctentity
AT grunebaumlelia covid19relatedcoagulopathyadistinctentity
AT morelolivier covid19relatedcoagulopathyadistinctentity

Ejemplares similares